Omada Health (OMDA) Competitors $17.38 -0.14 (-0.80%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock OMDA vs. PACS, LFST, ARDT, CELC, NHC, VRDN, TDOC, GRAL, AHCO, and AGLShould you be buying Omada Health stock or one of its competitors? The main competitors of Omada Health include PACS Group (PACS), LifeStance Health Group (LFST), Ardent Health (ARDT), Celcuity (CELC), National HealthCare (NHC), Viridian Therapeutics (VRDN), Teladoc Health (TDOC), GRAIL (GRAL), AdaptHealth (AHCO), and Agilon Health (AGL). These companies are all part of the "healthcare" industry. Omada Health vs. Its Competitors PACS Group LifeStance Health Group Ardent Health Celcuity National HealthCare Viridian Therapeutics Teladoc Health GRAIL AdaptHealth Agilon Health PACS Group (NYSE:PACS) and Omada Health (NASDAQ:OMDA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation. Does the media favor PACS or OMDA? In the previous week, PACS Group had 7 more articles in the media than Omada Health. MarketBeat recorded 10 mentions for PACS Group and 3 mentions for Omada Health. Omada Health's average media sentiment score of 0.74 beat PACS Group's score of 0.49 indicating that Omada Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral Omada Health 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is PACS or OMDA more profitable? Company Net Margins Return on Equity Return on Assets PACS GroupN/A N/A N/A Omada Health N/A N/A N/A Do analysts rate PACS or OMDA? PACS Group currently has a consensus price target of $34.29, indicating a potential upside of 222.84%. Omada Health has a consensus price target of $23.86, indicating a potential upside of 37.27%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than Omada Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PACS Group 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Omada Health 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, PACS or OMDA? PACS Group has higher revenue and earnings than Omada Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPACS Group$3.11B0.52$112.87MN/AN/AOmada HealthN/AN/AN/AN/AN/A SummaryPACS Group and Omada Health tied by winning 3 of the 6 factors compared between the two stocks. Get Omada Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMDA vs. The Competition Export to ExcelMetricOmada HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$451.14M$7.18B$5.47B$9.53BDividend YieldN/A2.90%4.74%4.08%P/E RatioN/A64.1328.6723.80Price / SalesN/A34.26422.2688.08Price / CashN/A25.7735.4557.96Price / BookN/A8.618.275.55Net IncomeN/A$239.96M$3.24B$259.03M7 Day Performance-9.53%-5.48%-3.63%-4.56%1 Month Performance-3.98%-3.73%4.40%4.49%1 Year PerformanceN/A18.27%25.97%18.05% Omada Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMDAOmada HealthN/A$17.38-0.8%$23.86+37.3%N/A$451.14MN/A0.00849PACSPACS Group3.0969 of 5 stars$11.87+1.5%$34.29+188.8%-70.3%$1.81B$3.11B0.0032,433News CoveragePositive NewsLFSTLifeStance Health Group3.1863 of 5 stars$4.16+0.4%$8.42+102.6%-32.4%$1.62B$1.25B-41.5510,218News CoverageUpcoming EarningsARDTArdent Health3.5872 of 5 stars$10.77-2.6%$20.30+88.5%-43.2%$1.54B$6.02B6.6124,900Upcoming EarningsCELCCelcuity0.851 of 5 stars$39.47+186.7%$28.25-28.4%+122.5%$1.49BN/A-13.0040Insider TradeAnalyst RevisionHigh Trading VolumeNHCNational HealthCareN/A$96.18-0.2%N/A-29.0%$1.49B$1.37B12.0512,400VRDNViridian Therapeutics1.0568 of 5 stars$17.76+2.7%$37.56+111.5%+6.9%$1.45B$300K-4.6150News CoverageShort Interest ↑TDOCTeladoc Health3.456 of 5 stars$8.19-0.2%$9.67+18.2%-19.2%$1.44B$2.57B-1.395,500News CoverageEarnings ReportAnalyst RevisionGRALGRAIL1.1932 of 5 stars$38.50-4.4%$31.50-18.2%+97.1%$1.39B$125.60M-0.631,360Gap DownAHCOAdaptHealth4.0649 of 5 stars$9.56+1.3%$13.40+40.2%-21.2%$1.29B$3.26B16.7710,500Upcoming EarningsAGLAgilon Health1.63 of 5 stars$2.05-0.7%$4.71+130.5%-74.2%$846.53M$6.06B-3.471,076Upcoming Earnings Related Companies and Tools Related Companies PACS Group Competitors LifeStance Health Group Competitors Ardent Health Competitors Celcuity Competitors National HealthCare Competitors Viridian Therapeutics Competitors Teladoc Health Competitors GRAIL Competitors AdaptHealth Competitors Agilon Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OMDA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omada Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omada Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
